欧盟EMA药品数据库-欧盟集中审批药品
(European Medicines Agency Authorisation of Medicines DataBase)
商品名称 适用类别 通用名称 活性成分 产品号 上市许可开发者/申请人/持有人 上市许可日期 许可状态
Lorviqua Human lorlatinib Lorlatinib EMEA/H/C/004646 Pfizer Europe MA EEIG 2019/05/06 Authorised
Pazenir Human paclitaxel paclitaxel EMEA/H/C/004441 ratiopharm GmbH 2019/05/06 Authorised
Waylivra Human volanesorsen volanesorsen sodium EMEA/H/C/004538 Akcea Therapeutics Ireland Limited 2019/05/03 Authorised
Palynziq Human pegvaliase pegvaliase EMEA/H/C/004744 BioMarin International Limited 2019/05/03 Authorised
Skyrizi Human risankizumab risankizumab EMEA/H/C/004759 AbbVie Deutschland GmbH & Co. KG 2019/04/26 Authorised
Ondexxya Human andexanet alfa andexanet alfa EMEA/H/C/004108 AstraZeneca AB 2019/04/26 Authorised
Dectova Human zanamivir zanamivir EMEA/H/C/004102 GlaxoSmithKline Trading Services Limited 2019/04/26 Authorised
Zynquista Human sotagliflozin sotagliflozin EMEA/H/C/004889 Guidehouse Germany GmbH 2019/04/26 Withdrawn
Idacio Human adalimumab adalimumab EMEA/H/C/004475 Fresenius Kabi Deutschland GmbH 2019/04/02 Authorised
Vizimpro Human dacomitinib dacomitinib monohydrate EMEA/H/C/004779 Pfizer Europe MA EEIG 2019/04/02 Authorised
Kromeya Human adalimumab adalimumab EMEA/H/C/005158 Fresenius Kabi Deutschland GmbH 2019/04/02 Withdrawn
Ajovy Human fremanezumab fremanezumab EMEA/H/C/004833 Teva GmbH 2019/03/28 Authorised
Febuxostat Krka Human febuxostat febuxostat EMEA/H/C/004773 Krka, d.d., Novo mesto 2019/03/28 Authorised
Atazanavir Krka Human atazanavir atazanavir (as sulfate) EMEA/H/C/004859 Krka, d.d., Novo mesto 2019/03/25 Authorised
Rizmoic Human naldemedine naldemedine tosilate EMEA/H/C/004256 Shionogi B.V. 2019/02/18 Authorised
Miglustat Dipharma Human miglustat miglustat EMEA/H/C/004904 Dipharma Arzneimittel GmbH 2019/02/18 Authorised
Mulpleo (previously Lusutrombopag Shionogi) Human lusutrombopag Lusutrombopag EMEA/H/C/004720 Shionogi B.V. 2019/02/18 Authorised
Vantobra (previously Tobramycin PARI) Human tobramycin tobramycin EMEA/H/C/005086 Pari Pharma GmbH 2019/02/18 Authorised
Besremi Human ropeginterferon alfa-2b ropeginterferon alfa-2b EMEA/H/C/004128 AOP Orphan Pharmaceuticals GmbH 2019/02/15 Authorised
Zirabev Human bevacizumab bevacizumab EMEA/H/C/004697 Pfizer Europe MA EEIG 2019/02/14 Authorised

数据库说明:

©2006-2026 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase